MSB 1.03% 98.0¢ mesoblast limited

Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-96

  1. 3,865 Posts.
    lightbulb Created with Sketch. 1308
    Very positive announcement. I think it is now time for a conference call. The announcement is a bit short on detail. Have we had the meeting or not ? The GVHD trial. Has the potency assay been approved.

    What my takeaway is that the FDA is not just meeting there time frames but beating them and making decisions way faster than they could. This decision could have been left till the 30 days post meeting had lapsed.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
98.0¢
Change
0.010(1.03%)
Mkt cap ! $1.118B
Open High Low Value Volume
96.0¢ 99.0¢ 95.5¢ $5.286M 5.409M

Buyers (Bids)

No. Vol. Price($)
3 91218 98.0¢
 

Sellers (Offers)

Price($) Vol. No.
99.0¢ 63577 4
View Market Depth
Last trade - 16.10pm 27/06/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.